Inclusion Criteria : 
  -  Healthy male and female subjects ( aged 19 ~ 45 years at the time of screening ) 
  -  Subjects weighing between 50 kg ( inclusive ) and 90 kg ( exclusive )  , and having a body mass index ( BMI ) of 17.1 ～25.8 ( inclusive of limits ) . 
  -  Subjects with a fasting plasma glucose ( FPG ) of 70 ～110 mg / dL ( inclusive of limits ) at the time of screening
  -  Subjects who are willing to participate in the entire study cycle and comply with the study protocol ( including contraception ) .  Subjects who can sign the written Informed Consent Form after being informed of the study procedures. 
Exclusion Criteria : 
  -  Those with a history of allergies including drug allergies ( aspirin , antibiotics , etc. )  , or other clinically significant allergies. 
  -  Those with diseases of the liver ( including carriers of hepatitis virus )  , kidney , respiratory system , endocrine system , nervous system or immune system.  Those with a medical history of hematology / oncology , psychiatry or cardiovascular diseases. 
  -  Those with a medical history of gastrointestinal diseases ( ulcers , Crohn's disease , etc. ) or surgery ( excluding simple appendectomy or hernia repair )  , and these situations can affect the absorption of the study drug.